Cytek BioSciences

Cell analyzer manufacturer.

Orders closed

Product price:

$17.00

IPO Date:
2021.07.23
Industry:
Health Care
Lockup Expiration:
2021.10.24
Cytek BioSciences is a leading cell analysis solutions company creating a new generation of cell analysis tools using new technical approaches. The company's goal is to become a leading company in the field of cell analysis through continuous innovation. The main instruments, the Aurora and Northern Lights systems, are the first to provide high resolution, high count and high sensitivity cell analysis.
COMPANY'S INFORMATION
Site:
http://www.cytekbio.com
Employees:
391
Revenues:
$99,100,000
Net Income:
$20,400,000
IPO DETAILS
Ticker:
CTKB
Price min:
$17.00
Price max:
$17.00
Number of shares:
14,600,000
Placement volume:
$248,200,000
Capitalization:
$2,223,700,000
Exchange:
NASDAQ
Underwriter:
Morgan Stanley
Prospectus:
https://www.sec.gov/cgi-bin/browse-edgar?company=Cytek+&match=&filenum=&State=&Country=&SIC=&myowner=exclude&action=getcompany
11th Floor, 18 Harbour Road, Central Plaza
Wanchai, Hong Kong Island, Hong Kong
IPO LIMITED © Copyright 2016-2021
All Rights Reserved
Coming soon

Investing in an IPO is a high-risk instrument. Past investment results do not guarantee future returns. The online platform IPO.LIMITED does not guarantee and does not promise future return on investment, does not guarantee the reliability of potential investments and the stability of the profit margins. You should consider whether you understand how IPOs work and whether you can afford to risk losing some of your money.

Any information contained on the IPO.LIMITED online platform is provided for informational purposes only, is not a public offer and should not be construed as an offer to invest.

The online platform IPO.LIMITED supports the execution of collective orders for the over-the-counter purchase of shares prior to their actual entry into the stock market and does not provide any kind of financial services, banking or lending activities, asset management services, exchange or cryptocurrency trading, or providing services or advice on transactions with securities. All types of services provided on the IPO.LIMITED online platform are not licensed activities. At the same time, they are fully regulated by the current legislation and regulations and are strictly observed.

The online platform IPO.LIMITED does not provide any services and does not enter into business communications of any kind to residents and official representatives of residents of the United States, Japan, China, dependent territories and special administrative regions of the People's Republic of China, all member states of the Commonwealth of Nations, including Great Britain, Canada, Australia and New Zealand, as well as other countries and territories whose legislation may consider transactions carried out on the online platform as licensed or requiring special government registration or separate regulation or certification.

An IPO is the first public sale of shares of a private company on the stock market. Going to the IPO, the company for the first time offers to buy its securities to everyone. The IPO LIMITED team set itself the task of making it possible to invest in an IPO for everyone. even those who can afford to invest only $ 10. We simplified the entry process as much as possible, lowered the entry threshold, making it possible to remain anonymous in such transactions, and also take a commission only from those who withdraw money from the IPO LIMITED platform. The IPO LIMITED team has been investing in IPOs since 2016. you can look at the reviews about IPO LIMITED on a special page. IPO LIMITED is a company that will help you invest in an IPO with maximum security. In addition, IPO LIMITED provides advice and analytics for our users. We are always happy to help in investing in an IPO.